List of Tables
Table 1. Global Drugs of UDCA and t-UDCA Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Drugs of UDCA and t-UDCA Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Drugs of UDCA and t-UDCA Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Drugs of UDCA and t-UDCA Covered in This Study
Table 5. Global Drugs of UDCA and t-UDCA Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Drugs of UDCA and t-UDCA Sales Share by Manufacturers (2016-2021)
Table 7. Global Drugs of UDCA and t-UDCA Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Drugs of UDCA and t-UDCA Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Drugs of UDCA and t-UDCA Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Drugs of UDCA and t-UDCA Manufacturing Sites and Area Served
Table 11. Manufacturers Drugs of UDCA and t-UDCA Product Type
Table 12. Global Drugs of UDCA and t-UDCA Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Drugs of UDCA and t-UDCA by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs of UDCA and t-UDCA as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Drugs of UDCA and t-UDCA Sales by Region (2016-2021) & (K Units)
Table 16. Global Drugs of UDCA and t-UDCA Sales Market Share by Region (2016-2021)
Table 17. Global Drugs of UDCA and t-UDCA Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Drugs of UDCA and t-UDCA Sales by Country (2016-2021) & (K Units)
Table 19. North America Drugs of UDCA and t-UDCA Sales Market Share by Country (2016-2021)
Table 20. North America Drugs of UDCA and t-UDCA Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Drugs of UDCA and t-UDCA Revenue Market Share by Country (2016-2021)
Table 22. Europe Drugs of UDCA and t-UDCA Sales by Country (2016-2021) & (K Units)
Table 23. Europe Drugs of UDCA and t-UDCA Sales Market Share by Country (2016-2021)
Table 24. Europe Drugs of UDCA and t-UDCA Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Drugs of UDCA and t-UDCA Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Drugs of UDCA and t-UDCA Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Drugs of UDCA and t-UDCA Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Drugs of UDCA and t-UDCA Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Drugs of UDCA and t-UDCA Revenue Market Share by Region (2016-2021)
Table 30. Latin America Drugs of UDCA and t-UDCA Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Drugs of UDCA and t-UDCA Sales Market Share by Country (2016-2021)
Table 32. Latin America Drugs of UDCA and t-UDCA Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Drugs of UDCA and t-UDCA Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Drugs of UDCA and t-UDCA Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Drugs of UDCA and t-UDCA Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Drugs of UDCA and t-UDCA Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Drugs of UDCA and t-UDCA Revenue Market Share by Country (2016-2021)
Table 38. Global Drugs of UDCA and t-UDCA Sales (K Units) by Type (2016-2021)
Table 39. Global Drugs of UDCA and t-UDCA Sales Market Share by Type (2016-2021)
Table 40. Global Drugs of UDCA and t-UDCA Revenue (Million US$) by Type (2016-2021)
Table 41. Global Drugs of UDCA and t-UDCA Revenue Share by Type (2016-2021)
Table 42. Global Drugs of UDCA and t-UDCA Price (US$/Unit) by Type (2016-2021)
Table 43. Global Drugs of UDCA and t-UDCA Sales (K Units) by Application (2016-2021)
Table 44. Global Drugs of UDCA and t-UDCA Sales Market Share by Application (2016-2021)
Table 45. Global Drugs of UDCA and t-UDCA Revenue (Million US$) by Application (2016-2021)
Table 46. Global Drugs of UDCA and t-UDCA Revenue Share by Application (2016-2021)
Table 47. Global Drugs of UDCA and t-UDCA Price (US$/Unit) by Application (2016-2021)
Table 48. Dr. Falk Pharma Corporation Information
Table 49. Dr. Falk Pharma Description and Business Overview
Table 50. Dr. Falk Pharma Drugs of UDCA and t-UDCA Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Dr. Falk Pharma Drugs of UDCA and t-UDCA Product
Table 52. Dr. Falk Pharma Recent Developments/Updates
Table 53. Daewoong Pharmaceutical Corporation Information
Table 54. Daewoong Pharmaceutical Description and Business Overview
Table 55. Daewoong Pharmaceutical Drugs of UDCA and t-UDCA Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Daewoong Pharmaceutical Drugs of UDCA and t-UDCA Product
Table 57. Daewoong Pharmaceutical Recent Developments/Updates
Table 58. Teva Corporation Information
Table 59. Teva Description and Business Overview
Table 60. Teva Drugs of UDCA and t-UDCA Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Teva Drugs of UDCA and t-UDCA Product
Table 62. Teva Recent Developments/Updates
Table 63. Epic Pharma Corporation Information
Table 64. Epic Pharma Description and Business Overview
Table 65. Epic Pharma Drugs of UDCA and t-UDCA Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Epic Pharma Drugs of UDCA and t-UDCA Product
Table 67. Epic Pharma Recent Developments/Updates
Table 68. Mitsubishi Tanabe Pharma Corporation Information
Table 69. Mitsubishi Tanabe Pharma Description and Business Overview
Table 70. Mitsubishi Tanabe Pharma Drugs of UDCA and t-UDCA Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Mitsubishi Tanabe Pharma Drugs of UDCA and t-UDCA Product
Table 72. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 73. Lannett Corporation Information
Table 74. Lannett Description and Business Overview
Table 75. Lannett Drugs of UDCA and t-UDCA Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Lannett Drugs of UDCA and t-UDCA Product
Table 77. Lannett Recent Developments/Updates
Table 78. Mylan Corporation Information
Table 79. Mylan Description and Business Overview
Table 80. Mylan Drugs of UDCA and t-UDCA Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Mylan Drugs of UDCA and t-UDCA Product
Table 82. Mylan Recent Developments/Updates
Table 83. Bruschettini Corporation Information
Table 84. Bruschettini Description and Business Overview
Table 85. Bruschettini Drugs of UDCA and t-UDCA Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Bruschettini Drugs of UDCA and t-UDCA Product
Table 87. Bruschettini Recent Developments/Updates
Table 88. Impax Corporation Information
Table 89. Impax Description and Business Overview
Table 90. Impax Drugs of UDCA and t-UDCA Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Impax Drugs of UDCA and t-UDCA Product
Table 92. Impax Recent Developments/Updates
Table 93. Shanghai Pharma Corporation Information
Table 94. Shanghai Pharma Description and Business Overview
Table 95. Shanghai Pharma Drugs of UDCA and t-UDCA Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Shanghai Pharma Drugs of UDCA and t-UDCA Product
Table 97. Shanghai Pharma Recent Developments/Updates
Table 98. Grindeks Corporation Information
Table 99. Grindeks Description and Business Overview
Table 100. Grindeks Drugs of UDCA and t-UDCA Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Grindeks Drugs of UDCA and t-UDCA Product
Table 102. Grindeks Recent Developments/Updates
Table 103. Production Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Drugs of UDCA and t-UDCA Distributors List
Table 106. Drugs of UDCA and t-UDCA Customers List
Table 107. Drugs of UDCA and t-UDCA Market Trends
Table 108. Drugs of UDCA and t-UDCA Growth Drivers
Table 109. Drugs of UDCA and t-UDCA Market Restraints
Table 110. Global Drugs of UDCA and t-UDCA Sales Forecast by Type (2022-2027) & (K Units)
Table 111. Global Drugs of UDCA and t-UDCA Sales Market Share Forecast by Type (2022-2027)
Table 112. Global Drugs of UDCA and t-UDCA Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 113. Global Drugs of UDCA and t-UDCA Revenue Market Share Forecast by Type (2022-2027)
Table 114. Global Drugs of UDCA and t-UDCA Sales Forecast by Application (2022-2027) & (K Units)
Table 115. Global Drugs of UDCA and t-UDCA Sales Market Share Forecast by Application (2022-2027)
Table 116. Global Drugs of UDCA and t-UDCA Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 117. Global Drugs of UDCA and t-UDCA Revenue Market Share Forecast by Application (2022-2027)
Table 118. Global Drugs of UDCA and t-UDCA Sales Forecast by Region (2022-2027) & (K Units)
Table 119. Global Drugs of UDCA and t-UDCA Sales Market Share Forecast by Region (2022-2027)
Table 120. Global Drugs of UDCA and t-UDCA Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 121. Global Drugs of UDCA and t-UDCA Revenue Market Share Forecast by Region (2022-2027)
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Drugs of UDCA and t-UDCA
Figure 2. Global Drugs of UDCA and t-UDCA Market Share by Type in 2020 & 2027
Figure 3. t-UDCA Product Picture
Figure 4. UDCA Product Picture
Figure 5. Global Drugs of UDCA and t-UDCA Market Share by Application in 2020 & 2027
Figure 6. Gallstone
Figure 7. Hepatopathy
Figure 8. Biliary Disease
Figure 9. Other
Figure 10. Global Drugs of UDCA and t-UDCA Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Drugs of UDCA and t-UDCA Market Size 2016-2027 (US$ Million)
Figure 12. Global Drugs of UDCA and t-UDCA Sales 2016-2027 (K Units)
Figure 13. Global Drugs of UDCA and t-UDCA Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Drugs of UDCA and t-UDCA Sales Share by Manufacturers in 2020
Figure 15. Global Drugs of UDCA and t-UDCA Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Drugs of UDCA and t-UDCA Players: Market Share by Revenue in 2020
Figure 17. Drugs of UDCA and t-UDCA Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Drugs of UDCA and t-UDCA Sales Market Share by Region (2016-2021)
Figure 19. Global Drugs of UDCA and t-UDCA Sales Market Share by Region in 2020
Figure 20. Global Drugs of UDCA and t-UDCA Revenue Market Share by Region (2016-2021)
Figure 21. Global Drugs of UDCA and t-UDCA Revenue Market Share by Region in 2020
Figure 22. United States Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Colombia Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Drugs of UDCA and t-UDCA Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Drugs of UDCA and t-UDCA by Type (2016-2021)
Figure 46. Sales Market Share of Drugs of UDCA and t-UDCA by Application (2016-2021)
Figure 47. Sales Market Share of Drugs of UDCA and t-UDCA by Application in 2020
Figure 48. Revenue Share of Drugs of UDCA and t-UDCA by Application (2016-2021)
Figure 49. Revenue Share of Drugs of UDCA and t-UDCA by Application in 2020
Figure 50. Manufacturing Cost Structure of Drugs of UDCA and t-UDCA
Figure 51. Manufacturing Process Analysis of Drugs of UDCA and t-UDCA
Figure 52. Drugs of UDCA and t-UDCA Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

LIST OF FIGURE